HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VIGONVITA-B

100.000

+0.8000.81%

Volume:42.20K

Turnover:4.20M

Market Cap:16.80B

PE:-36.80

High:107.000

Open:99.150

Low:95.000

Close:99.200

52wk High:134.900

52wk Low:51.000

Shares:168.00M

HK Float Shares:167.00M

Volume Ratio:0.93

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.718

ROE:-123.98%

ROA:-20.73%

PB:67.14

PE(LYR):-36.80

PS:66.29

Loading ...

Overview Company News Filings

Vigonvita Life Sciences' 2025 Loss Widens

MT Newswires Live

Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing

Vigonvita proposes bylaw change to lift registered capital to RMB 168 million after H-share IPO

Vigonvita Life Sciences schedules extraordinary general meeting, sets share register book closure period

VIGONVITA-B Reports FY2025 Results: Shareholder Loss Widens to 356 Million Yuan

BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 Million

Vigonvita Life Sciences 2025: Revenue Jumps 7.63-fold but Loss Widens on Share-Based Payments and IPO Costs

Bulletin Express

Vigonvita Life Sciences Co Ltd - FY Total Loss Attributable RMB355.7 Mln

THOMSON REUTERS

Vigonvita Life Sciences Proposes Articles Amendment After H-Share Listing; Registered Capital to Rise to RMB167.60 Million

Bulletin Express

VIGONVITA-B (02630) EGM Green-lights H Share Award Scheme with 100% Support

Bulletin Express

Vigonvita Life Sciences Co. Ltd. held an extraordinary general meeting with 72.79% shareholder attendance

VIGONVITA-B (02630) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

VIGONVITA-B (02630) Announces Monthly Capital Structure Update

Bulletin Express

Vigonvita Life Sciences (2630) Announces EGM on March 19, 2026 to Consider H Share Award Scheme

Bulletin Express

Vigonvita Life Sciences (2630) Announces EGM and Proposes H Share Award Scheme

Bulletin Express

Vigonvita Life Sciences Co. Ltd. Announces Extraordinary General Meeting

Vigonvita Life Sciences (2630) Proposes Trustee Change for H Share Award Scheme

Bulletin Express

VIGONVITA-B (02630) Announces Change in Trustee for H-Share Reward Scheme

Vigonvita Life Sciences (2630) Announces Book Closure Period for EGM

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/02630/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"VIGONVITA-B","latestPrice":100,"timestamp":1788234739684,"preClose":99.2,"halted":0,"volume":42200,"delay":0,"changeRate":0.008064516129032228,"floatShares":167000000,"shares":168000000,"eps":-2.717751891192725,"marketStatus":"Noon Closed","change":0.8,"latestTime":"09-01 11:52:19","open":99.15,"high":107,"low":95,"amount":4201180,"amplitude":0.120968,"askPrice":101.8,"askSize":200,"bidPrice":100,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":-2.207502721749696,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788238800000},"marketStatusCode":3,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":99.2,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.932481,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","floatShares":167000000,"roa":"-20.73%","roe":"-123.98%","lyrEps":-2.717737,"volumeRatio":0.932481,"shares":168000000,"dividePrice":0,"high":107,"amplitude":0.120968,"preClose":99.2,"low":95,"week52Low":51,"pbRate":"67.14","psRate":"66.29","week52High":134.9,"institutionHeld":0,"latestPrice":100,"committee":0.714286,"eps":-2.717736665516917,"divideRate":0,"volume":42200,"delay":0,"ttmEps":-2.207490354645511,"open":99.15,"prevYearClose":81.85,"prevWeekClose":99.65,"prevMonthClose":99.2,"prevQuarterClose":63.55,"fiveDayClose":93.45,"twentyDayClose":95.4,"sixtyDayClose":65.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02630\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-31","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02630","date":"2026-08-31","current":-45.300057,"percent":0.020101,"low":-51.703739,"twenty":-31.753723,"median":-23.964643,"eighty":-17.097406,"high":-9.647367,"avg":-24.970479,"sd":8.425317,"marketCap":16625701760},"quantilePoints":[{"date":"2025-11-07","current":-19.090342,"twenty":-21.84559,"median":-19.090342,"eighty":-13.424557,"marketCap":4407358491},{"date":"2025-11-14","current":-19.641187,"twenty":-19.420849,"median":-16.095168,"eighty":-15.264414,"marketCap":4547380470},{"date":"2025-11-21","current":-17.28769,"twenty":-19.452561,"median":-18.09445,"eighty":-15.501254,"marketCap":4000627980},{"date":"2025-11-28","current":-20.095977,"twenty":-19.591091,"median":-19.037434,"eighty":-16.046947,"marketCap":4667399310},{"date":"2025-12-05","current":-22.096294,"twenty":-21.259546,"median":-19.451229,"eighty":-16.716837,"marketCap":5140806954},{"date":"2025-12-12","current":-20.997063,"twenty":-21.601599,"median":-19.578567,"eighty":-17.610394,"marketCap":4894101562},{"date":"2025-12-19","current":-23.416326,"twenty":-21.853997,"median":-20.095977,"eighty":-18.35497,"marketCap":5470858762},{"date":"2025-12-24","current":-23.9553,"twenty":-22.587001,"median":-20.380599,"eighty":-18.745749,"marketCap":5614214598},{"date":"2026-01-02","current":-23.818881,"twenty":-23.195416,"median":-20.975608,"eighty":-18.936771,"marketCap":5604213028},{"date":"2026-01-09","current":-24.028271,"twenty":-23.242124,"median":-21.499422,"eighty":-19.069179,"marketCap":5667556305},{"date":"2026-01-16","current":-25.359291,"twenty":-23.625318,"median":-21.781264,"eighty":-19.370201,"marketCap":6000941970},{"date":"2026-01-23","current":-26.793845,"twenty":-23.828886,"median":-22.096294,"eighty":-19.449016,"marketCap":6334327635},{"date":"2026-01-30","current":-27.921283,"twenty":-24.928673,"median":-22.61666,"eighty":-19.453005,"marketCap":6631040876},{"date":"2026-02-06","current":-29.544924,"twenty":-25.987891,"median":-22.879289,"eighty":-19.503447,"marketCap":7034437531},{"date":"2026-02-13","current":-30.629205,"twenty":-27.286118,"median":-23.1966,"eighty":-19.616139,"marketCap":7334484630},{"date":"2026-02-20","current":-34.884005,"twenty":-27.587073,"median":-23.306067,"eighty":-19.674728,"marketCap":8341309338},{"date":"2026-02-27","current":-31.168111,"twenty":-28.783656,"median":-23.424434,"eighty":-19.866309,"marketCap":7534516029},{"date":"2026-03-06","current":-27.5285,"twenty":-28.691787,"median":-23.667752,"eighty":-20.125096,"marketCap":6601036167},{"date":"2026-03-13","current":-30.889856,"twenty":-29.277344,"median":-23.818881,"eighty":-20.297184,"marketCap":7441168042},{"date":"2026-03-20","current":-35.008205,"twenty":-30.149829,"median":-23.991785,"eighty":-20.606532,"marketCap":8401318758},{"date":"2026-03-27","current":-24.261842,"twenty":-30.04822,"median":-24.440897,"eighty":-20.962736,"marketCap":5807578284},{"date":"2026-04-02","current":-13.839173,"twenty":-29.95186,"median":-24.028271,"eighty":-20.954154,"marketCap":5600879172},{"date":"2026-04-10","current":-14.403566,"twenty":-29.707698,"median":-23.912102,"eighty":-20.183335,"marketCap":5874255417},{"date":"2026-04-17","current":-13.931767,"twenty":-29.472848,"median":-23.687448,"eighty":-19.490947,"marketCap":5684225588},{"date":"2026-04-24","current":-13.154764,"twenty":-29.345649,"median":-23.63573,"eighty":-19.048016,"marketCap":5367509206},{"date":"2026-04-30","current":-11.730061,"twenty":-29.261806,"median":-23.42038,"eighty":-17.610394,"marketCap":4787418149},{"date":"2026-05-08","current":-12.584922,"twenty":-29.118763,"median":-23.285925,"eighty":-15.264414,"marketCap":5154142380},{"date":"2026-05-15","current":-12.982213,"twenty":-28.928188,"median":-23.15168,"eighty":-14.197911,"marketCap":5330836783},{"date":"2026-05-22","current":-13.28049,"twenty":-28.680958,"median":-22.671486,"eighty":-13.975486,"marketCap":5440854052},{"date":"2026-05-29","current":-30.758632,"twenty":-28.951155,"median":-22.671486,"eighty":-13.922465,"marketCap":12645254010},{"date":"2026-06-05","current":-26.663627,"twenty":-28.786309,"median":-23.15168,"eighty":-13.953626,"marketCap":10977655900},{"date":"2026-06-12","current":-24.767111,"twenty":-28.478214,"median":-23.285925,"eighty":-14.04116,"marketCap":10189946240},{"date":"2026-06-18","current":-23.79348,"twenty":-28.413466,"median":-23.416326,"eighty":-14.041546,"marketCap":9812851190},{"date":"2026-06-26","current":-24.094013,"twenty":-28.02179,"median":-23.475951,"eighty":-14.17377,"marketCap":9888270200},{"date":"2026-07-03","current":-23.973985,"twenty":-27.941384,"median":-23.572922,"eighty":-14.1825,"marketCap":9846370750},{"date":"2026-07-10","current":-22.062739,"twenty":-27.729315,"median":-23.424434,"eighty":-14.21114,"marketCap":9050281200},{"date":"2026-07-17","current":-23.043014,"twenty":-27.655709,"median":-23.42038,"eighty":-14.359864,"marketCap":9486035480},{"date":"2026-07-24","current":-31.748257,"twenty":-27.941384,"median":-23.52511,"eighty":-14.401931,"marketCap":13072628400},{"date":"2026-07-31","current":-38.65537,"twenty":-28.640355,"median":-23.612983,"eighty":-14.919422,"marketCap":15946930670},{"date":"2026-08-07","current":-47.358881,"twenty":-29.345649,"median":-23.667752,"eighty":-15.264958,"marketCap":19575423040},{"date":"2026-08-14","current":-37.215568,"twenty":-30.11107,"median":-23.79348,"eighty":-15.618859,"marketCap":15402237820},{"date":"2026-08-21","current":-35.214198,"twenty":-30.680976,"median":-23.843893,"eighty":-16.143388,"marketCap":14606148270},{"date":"2026-08-28","current":-40.255874,"twenty":-31.400169,"median":-23.9553,"eighty":-16.907121,"marketCap":16701120770},{"date":"2026-08-31","current":-46.792353,"twenty":-31.753723,"median":-23.964643,"eighty":-17.097406,"marketCap":16625701760}],"updateTime":1788237316617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02630\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624569473","title":"Vigonvita Life Sciences' 2025 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2624569473","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624569473?lang=en_us&edition=fundamental","pubTime":"2026-04-01 12:46","pubTimestamp":1775018812,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences  booked 355.7 million yuan in loss for 2025, 68% higher from the 211.4 million yuan loss booked in 2024, according to a Hong Kong bourse filing Tuesday.Shares of the drug discovery firm gained over 3% in late morning trade Wednesday.Loss per share was 2.33 yuan, compared with 1.45 yuan in the prior year.Revenue rose to 102.1 million yuan from 11.8 million yuan in 2024.The firm attributed the increase in revenue to the marketing approval of its TPN171 drug during the year, as well as milestone payments tied to the VV116 medicine.The company did not declare any dividend for the year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119592422","title":"Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1119592422","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119592422?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:59","pubTimestamp":1775008770,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.The surge follows the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624109556","title":"Vigonvita proposes bylaw change to lift registered capital to RMB 168 million after H-share IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2624109556","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624109556?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:12","pubTimestamp":1774995124,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences proposed bylaw amendments to reflect changes following H-share listing on Nov. 6, 2025.Registered capital would be updated to RMB 168 million from RMB 150 million.Changes would require shareholder clearance via special resolution at forthcoming extraordinary general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL4919vT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624556659","title":"Vigonvita Life Sciences schedules extraordinary general meeting, sets share register book closure period","url":"https://stock-news.laohu8.com/highlight/detail?id=2624556659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624556659?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:04","pubTimestamp":1774994692,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences scheduled an extraordinary general meeting for April 23, 2026 at 10:00 a.m. in Suzhou, China.H-share register will close April 20-23, 2026 to set voting eligibility for the meeting.H-share transfer deadline for meeting eligibility set for April 17, 2026 at 4:30 p.m. Hong Kong time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL53vPYl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166352107","title":"VIGONVITA-B Reports FY2025 Results: Shareholder Loss Widens to 356 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1166352107","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166352107?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:58","pubTimestamp":1774972704,"startTime":"0","endTime":"0","summary":"VIGONVITA-B (02630) announced its annual results for the period ended December 31, 2025. The company recorded revenue of 102 million yuan, representing a significant increase of 762.9% compared to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533184","title":"BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623533184?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:23","pubTimestamp":1774970639,"startTime":"0","endTime":"0","summary":"BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 MillionMarch 31 (Reuters) - Vigonvita Life Sciences Co Ltd 2630.HK:FY TOTAL LOSS ATTRIBUTABLE RMB355.7 MILLIONFY REVENUE RMB102.1 MILLIONFurther company coverage: 2630.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159080130","title":"Vigonvita Life Sciences 2025: Revenue Jumps 7.63-fold but Loss Widens on Share-Based Payments and IPO Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=1159080130","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159080130?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:07","pubTimestamp":1774969638,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. reported audited results for the year ended 31 December 2025. Financial Snapshot   • Revenue surged to RMB 102.10 million, up 762.9% year-on-year, driven by the July...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623453814","title":"Vigonvita Life Sciences Co Ltd -  FY Total Loss Attributable RMB355.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623453814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623453814?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:52","pubTimestamp":1774968761,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130638221","title":"Vigonvita Life Sciences Proposes Articles Amendment After H-Share Listing; Registered Capital to Rise to RMB167.60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1130638221","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130638221?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:27","pubTimestamp":1774967232,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has released an announcement detailing plans to amend multiple clauses in its Articles of Association following the company’s H-share listing on 6...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158487800","title":"VIGONVITA-B (02630) EGM Green-lights H Share Award Scheme with 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1158487800","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158487800?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:00","pubTimestamp":1773928859,"startTime":"0","endTime":"0","summary":"On 19 March 2026, Vigonvita-B (02630) announced the poll results of its Extraordinary General Meeting held the same day in Suzhou. The sole agenda item—adoption of an H Share Award Scheme and related...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620265022","title":"Vigonvita Life Sciences Co. Ltd. held an extraordinary general meeting with 72.79% shareholder attendance","url":"https://stock-news.laohu8.com/highlight/detail?id=2620265022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620265022?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:45","pubTimestamp":1773927940,"startTime":"0","endTime":"0","summary":"Shareholders approved the adoption of the H Share Award Scheme.The meeting also approved authorizing the board to handle matters related to the H Share Award Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLw5zX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130554739","title":"VIGONVITA-B (02630) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1130554739","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130554739?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:23","pubTimestamp":1773872594,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B, 02630) has announced that its board of directors will convene on 31 March 2026. The agenda includes: • Reviewing and approving the Group’s audited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188637829","title":"VIGONVITA-B (02630) Announces Monthly Capital Structure Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1188637829","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188637829?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:25","pubTimestamp":1772663113,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (stock code: 02630) has issued a monthly update for the period ended 28 February 2026. According to the announcement dated 5 March 2026, the total authorized share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159419752","title":"Vigonvita Life Sciences (2630) Announces EGM on March 19, 2026 to Consider H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1159419752","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159419752?lang=en_us&edition=fundamental","pubTime":"2026-03-02 23:02","pubTimestamp":1772463726,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of the notice from Vigonvita Life Sciences Co., Ltd. (the “Company”), make...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120033213","title":"Vigonvita Life Sciences (2630) Announces EGM and Proposes H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1120033213","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120033213?lang=en_us&edition=fundamental","pubTime":"2026-03-02 23:01","pubTimestamp":1772463712,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (Stock code: 2630) has scheduled an Extraordinary General Meeting (EGM) for Thursday, March 19, 2026, at 10:00 a.m. The venue for the EGM is on the 8th Floor,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616135594","title":"Vigonvita Life Sciences Co. Ltd. Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2616135594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616135594?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:46","pubTimestamp":1772462819,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co. Ltd. will hold an extraordinary general meeting on March 19, 2026 in Suzhou, PRC. Shareholders will vote on a special resolution to approve the adoption of the H Share Award Scheme and to authorize the board to handle matters relating to the H Share Award Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbFNLv5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115398179","title":"Vigonvita Life Sciences (2630) Proposes Trustee Change for H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1115398179","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115398179?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:01","pubTimestamp":1772456483,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (the “Company”) (Stock Code: 2630) issued an announcement regarding a proposed change of trustee for its H Share Award Scheme. According to the Company, JLT Trust...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171610101","title":"VIGONVITA-B (02630) Announces Change in Trustee for H-Share Reward Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1171610101","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171610101?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:52","pubTimestamp":1772455938,"startTime":"0","endTime":"0","summary":"VIGONVITA-B (02630) has announced that on March 2, 2026, in order to optimize the management efficiency and operational arrangements of its share reward scheme, the company proposed a change of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168223681","title":"Vigonvita Life Sciences (2630) Announces Book Closure Period for EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1168223681","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168223681?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:41","pubTimestamp":1772455279,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (2630) will hold an extraordinary general meeting on March 19, 2026, at 10:00 a.m. in Suzhou, China. The register of members of H Shares will be closed from March...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}